4th Boston Biotechnology Virtual Summit
September 10, 2020
www.bostonbiotechnologysummit.com
The 4th Boston ● Paris Biotechnology Virtual Summit ● Focus on Covid-19 – will be held, via a zoom platform, on Thursday 15 October 2020, 11 AM – 01 PM US EDT [17:00 – 19:00 EU CET] in three sequential panels as below.
The Program Committee, listed below*, have convened renowned experts to analyze and discuss the treatment/prevention of Covid-19, as well as its impact on the biotechnology industry. Their Covid-19 expertise ranges from the “trenches” of every day clinical care to the complexity of decision making. Event held in collaboration with Mass Bio Hub.
| Panel ①: Covid-19 Prevention. Full review of vaccines and public prevention policies. |
| Panel ②: Covid-19 Treatment. Full review of treatments in clinical trials and medical care. |
| Panel ③: Finance, Investment & Leadership in the new Covid-19 era. |
 www.bostonbiotechnologysummit.com | Shahin Gharakhanian, MD, DPHCo-Founder, Principal, & Program ChairShahin Gharakhanian MD Consulting LLCCIC: Cambridge Innovation CenterCambridge MA 02142, USA. |
———————————————————————————————————-
| *2020 International Program Committee | ||
| Christophe Arbet-Engels, MD, PhD, MBA CMO, Millendo Therapeutics, Ann Arbor MI. CCEF: Conseiller de Commerce Extérieur de la France ● French Foreign Trade Advisor. | Nicola La Monica, PhD, Senior Director, Infectious Disease Scientific Innovation,Johnson & Johnson, Boston MA. | Frederick E. “Rick” Pierce II. CEO & President, SanaRx Tx,Principal, FEP Capital Advisors, USA & China: Cambridge MA, New York, Beijing, Shanghai. |
| Pierre Courteille, Pharm., MBA Vice-President, FRANCE-BIOTECH,CCO, Abivax. Paris, France. | Cecile Le Camus, MD, MBA, Executive Director & Medical Lead, Vertex Pharmaceuticals,Boston MA. | Heather Steinman, PhD, MBA. Vice-President for BD & Executive Director of Technology Transfer, The Wistar Institute, Philadelphia PA. |
| Mark De Rosch, PhD, FRAPS Chief Regulatory Officer,Epizyme Inc, Cambridge MA. | Imran Nasrullah, PhD, Vice President & Head, Open Innovation Center North America – East at Bayer Pharmaceuticals,Cambridge MA, USA | Milos Todorovic, PhD, Trade Commissioner – Life Sciences, Consulate General of CANADA, Boston MA. |
| Marc Filerman, CEO, GERMANY Accelerator Life Sciences, Cambridge MA. | Tibor Nemes, MBA President, Stallergenes Greer,Boston MA. | ● SPECIAL ADVISOR TO ORGANIZING TEAM: Pravin Chaturvedi, PhD. CEO, Woburn MA. |
| *In alphabetical order |